Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. - Wikidata - wikimedia - TriplyDB

Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.

Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q37287058

about

Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer Collaborative Research in Childhood Cancer Survivorship: The Current Landscape Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study.Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation.Energy balance: an overview with emphasis on children Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort.Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study Modifiable risk factors and major cardiac events among adult survivors of childhood cancer.Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemia Body mass index and annual increase of body mass index in long-term childhood cancer survivors; relationship to treatment Cardiovascular risk and insulin resistance in childhood cancer survivors.Comparison of childhood cancer survivors' nutritional intake with US dietary guidelines.Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy.Adverse Fat Depots and Marrow Adiposity Are Associated With Skeletal Deficits and Insulin Resistance in Long-Term Survivors of Pediatric Hematopoietic Stem Cell Transplantation.Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.Obesity in Childhood Cancer Survivors: Call for Early Weight Management.Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia Premature Atherosclerotic Cardiovascular Disease in Childhood Cancer Survivors.Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia.Obesity and Metabolic Disease After Childhood Cancer Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia.Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study Cranial radiotherapy predisposes to abdominal adiposity in survivors of childhood acute lymphocytic leukemia.Adipokines and Insulin Resistance in Young Adult Survivors of Childhood Cancer.Milestones in the curability of pediatric cancers Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia.Endocrinological and cardiological late effects among survivors of childhood acute lymphoblastic leukemia.A population-based study of childhood cancer survivors' body mass index.Screening for vitamin D insufficiency in pediatric cancer survivors.Hyperglycemia in patients with hematologic malignancies.Early Nutrition and Physical Activity Interventions in Childhood Cancer Survivors.Cardiomyopathy in Childhood Cancer Survivors: Lessons from the Past and Challenges for the Future.Parenting Behaviors and Nutrition in Children with Leukemia.A cross-sectional study of overweight in pediatric survivors of acute lymphoblastic leukemia (ALL).

P2860

Q24197545-01FCA80B-7617-428F-9115-D5D0C0A2C658 Q28081135-ECA4ED59-492D-4572-8B12-3531748F5C72 Q28088408-C8C1EA9A-A235-4B8E-9292-7C6537DA9534 Q33822049-4201C5FE-448D-48B3-84F3-5D986ABC6638 Q34288406-DC90ED3B-2FF6-4963-A7AB-25C18D2ADB2C Q34433515-FD8D9463-C7A5-4A68-BFAD-3080FD232A20 Q34742645-035F29F9-4CD9-4DE7-AABD-30645455D6E5 Q34939208-842A556E-2296-42EC-9253-C8C1B489D3ED Q34977801-C5C89B61-ABB0-4494-8D8D-14E8B30A4588 Q35076156-183836BB-F012-4233-898B-0C7AAEE1D951 Q35106981-CA960E55-EBE1-480D-871D-4B8B7E3A917A Q35629592-57F7D76E-147C-46CB-92D1-B1C2D090F7F0 Q35635732-77D9AD70-A739-471B-9D15-F27719FA5167 Q35789041-BEAAEC46-46C1-41F3-AADD-7F9C2EC46182 Q35797623-D73307F7-05A6-44C9-B9CA-F61CD6500E1F Q35815806-B2337546-565E-49D1-8090-8C6EDAC763E8 Q35925270-9A64E7C8-F42D-45D4-82CE-589C29A455E2 Q35967618-F57BEDE7-18A3-4B24-B9D2-2552DE78517F Q36029249-92A0BEBC-6F1E-455F-9A34-6283D341E09E Q36033715-A18C4724-6710-47DE-8684-3CB1A92B87BE Q36279277-D7CC08B3-E3A3-4389-987D-D6125BE75EB6 Q36387214-1A89E8EE-CD4A-4AB1-95BF-AACAFA4D203B Q36461732-52DC455C-EFB6-4536-9838-031E38242AA0 Q36498620-8598B421-A316-462A-8DDC-129AE2782AA4 Q36569258-018613B9-2F21-44C0-ADD1-8C093C6DD491 Q36588407-1600FB8D-726E-41EE-80CF-726D255180DF Q36598564-73FC0EF0-44AE-4E5F-9237-8671544A334C Q36674961-0955860F-D3EA-4FFF-A432-37AE1DFCE27C Q36769572-D0DE061E-BEAE-4E35-8ACB-658626345E88 Q36880823-0DA63560-FC62-42D7-9957-4C0B1F7CF68B Q36925083-895A6932-DD1C-4402-ADAF-B5B5DB7616C4 Q37051195-2BE4EC94-197B-4051-8ED2-D45FDA16157A Q37426570-D8946BB9-DF70-4D23-AC64-121321584830 Q37553209-105048B6-7643-404D-9A8B-A4F0B7FB6BD4 Q37624193-D906D611-F14F-4E0E-9B4A-60FF80ECFEC0 Q38341651-90B90E18-4260-4026-8E69-DFCF4B048037 Q38689505-6E77D0AA-2B97-41A7-82A5-FC8ED586DD99 Q38753035-411335A5-4050-4961-8E2B-EA5EA1E39245 Q40629728-3C261FB4-90B3-4CF9-A11B-74FE5DE75F61 Q43408093-4544B79D-80E0-411F-A3FC-1340E2436497

P2860

Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q37287058

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Insulin resistance and risk fa ...... acute lymphoblastic leukemia.

@en

Insulin resistance and risk fa ...... acute lymphoblastic leukemia.

@nl

type

label

Insulin resistance and risk fa ...... acute lymphoblastic leukemia.

@en

Insulin resistance and risk fa ...... acute lymphoblastic leukemia.

@nl

prefLabel

Insulin resistance and risk fa ...... acute lymphoblastic leukemia.

@en

Insulin resistance and risk fa ...... acute lymphoblastic leukemia.

@nl

P1433

Q37287058-F57BA5B2-F867-4E11-97FE-5293862A28AB

P1476

Q37287058-1F19676F-1973-4FBE-ABD9-2BCB62F664C5

P2093

Q37287058-1BF56516-8CE3-49C3-9DF0-FD2A5E88A1F6

Q37287058-2842AAF1-6874-48CE-B784-E18AD6733ACC

Q37287058-3C452687-A726-4D1E-95C9-0AE7C8053094

Q37287058-5D4F8CD6-05E3-41D3-AFAB-A8473F065A16

Q37287058-89C63C54-7EC2-407C-9BC4-2484E0B95475

Q37287058-8D8C5402-FEF9-447E-A91F-EF5DDBCE5B96

Q37287058-9715D74A-D24E-42BF-A541-09440E4176AB

Q37287058-9CA29914-5151-4E33-983C-C3F76CBEA0A3

Q37287058-A2A703D4-ADA2-48BE-B14A-1FB82578EBF2

Q37287058-CAA39B52-07EA-4E98-8C29-7A3EAF9A3E0B

P2860

Q37287058-023D0DEA-5F53-496A-9B1C-C306637DEB39

Q37287058-02ECAB2F-924C-4E2D-A705-15EE28B95431

Q37287058-0D753033-BCE6-4CFD-A0B4-A875676FF92B

Q37287058-0E97CBCE-5BE3-4654-8E8F-9E2AF78650B8

Q37287058-1601540A-57E0-4B7C-AD58-111649E9F946

Q37287058-1642F085-345C-4399-ADE3-8CD63BAB76D3

Q37287058-175D7BF1-F7F1-4D31-8479-10A8DA879A67

Q37287058-236A2544-05AC-44B5-993F-C2597FF6DF87

Q37287058-29C84225-0CEA-49FD-A2B8-251FE80F11AC

Q37287058-2C82EEF6-0F28-45CA-A2FF-D4775D71FCB6

P304

Q37287058-0374E345-FC3F-42F1-8928-36FF195B0237

P31

Q37287058-53CEF3D2-AA06-40B5-9DB3-60A1AC0D410B

P356

Q37287058-60B6BCD6-0B7B-44A9-AAAA-3B0390E3A5B1

P407

Q37287058-E11B8CF2-E8AE-4493-B8FF-297197003310

P433

Q37287058-929BD0CD-8EDC-4246-96E2-22F5BBFCE4B6

P478

Q37287058-23FE4440-3C13-49F9-A7E7-E770BBAEADF9

P50

Q37287058-D0EBB295-3D1E-480C-91B3-75CDF0572C64

P577

Q37287058-3CA87A94-2EA6-4368-8CDC-AD6B549C817A

P698

Q37287058-CA7AACFE-7F58-4024-8C32-9084BB1DADBC

P921

Q37287058-63C2CA1F-812D-4D88-BC9C-325A4F884D91

Q37287058-9BC2EB37-7D5A-4943-8158-C3B5E89B07A5

Q37287058-FD7524DF-35F6-4D0A-B9B8-A7BF79504207

P932

Q37287058-AF45E96B-0F95-4234-B0C8-341541C3C551

P356

JCO.2008.19.7251

P1433

Journal of Clinical Oncology

P1476

Insulin resistance and risk fa ...... d acute lymphoblastic leukemia

@en

P2093

Alicia J Turoff

http://www.w3.org/2001/XMLSchema#string

Andrea L Dunn

http://www.w3.org/2001/XMLSchema#string

Beverley Adams-Huet

http://www.w3.org/2001/XMLSchema#string

Debra A Eshelman-Kent

http://www.w3.org/2001/XMLSchema#string

Gloria Lena Vega

http://www.w3.org/2001/XMLSchema#string

Kevin C Oeffinger

http://www.w3.org/2001/XMLSchema#string

Peter G Snell

http://www.w3.org/2001/XMLSchema#string

Robert Ross

http://www.w3.org/2001/XMLSchema#string

Ronald G Victor

http://www.w3.org/2001/XMLSchema#string

Sandra Brooks

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Use and abuse of HOMA modeling

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Chronic health conditions in adult survivors of childhood cancer.

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.

The assessment of insulin resistance in man.

Endocrine complications in pediatric patients with acute lymphoblastic leukemia.

Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study.

Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns.

C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.

P304

3698-3704

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.19.7251

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Peter M Janiszewski

P577

2009-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19564534

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

2720083

http://www.w3.org/2001/XMLSchema#string